Source:http://linkedlifedata.com/resource/pubmed/id/11463770
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2001-7-20
|
pubmed:abstractText |
The angiotensinogen M235T polymorphism has been linked to hypertension and cardiovascular disease. We studied the role of this polymorphism as a risk factor for carotid atherosclerosis and small-vessel disease-related brain abnormalities. A total of 431 randomly selected community-dwelling subjects without clinical evidence for strokes underwent angiotensinogen genotyping and carotid Duplex scanning; 1.5-T brain magnetic resonance imaging (MRI) was done in 396 individuals. At 3-year follow-up, we reexamined 343 and 267 study participants by ultrasound and brain MRI, respectively. Carotid atherosclerosis was graded on a 5-point scale. Small-vessel disease-related brain abnormalities were deep or subcortical white matter lesions or lacunes. Progression of carotid atherosclerosis and MRI findings was rated by direct imaging comparison by 3 independent raters. The M/M, M/T, and T/T genotypes were seen in 20.9%, 52.9%, and 18.1% of subjects, respectively. The M235T polymorphism was neither associated with baseline carotid findings nor with progression of carotid atherosclerosis. There was a trend toward more frequent small-vessel disease-related MRI abnormalities in the T/T than in the other genotypes at the baseline examination. Progression of brain lesions occurred significantly more commonly in T/T than in M/M and M/T carriers (P<0.001). Logistic regression analysis identified the T/T genotype (odds ratio, 3.19; P=0.002) and arterial hypertension (odds ratio, 3.06; P=0.03) as significant independent predictors of lesion progression. These data suggest that the angiotensinogen T/T genotype at position 235 is a genetic marker for brain lesions from and progression of small vessel disease but not for extracranial carotid atherosclerosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1524-4563
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
110-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11463770-Angiotensinogen,
pubmed-meshheading:11463770-Blood Vessels,
pubmed-meshheading:11463770-Carotid Artery Diseases,
pubmed-meshheading:11463770-Female,
pubmed-meshheading:11463770-Gene Frequency,
pubmed-meshheading:11463770-Genotype,
pubmed-meshheading:11463770-Humans,
pubmed-meshheading:11463770-Male,
pubmed-meshheading:11463770-Middle Aged,
pubmed-meshheading:11463770-Polymorphism, Genetic,
pubmed-meshheading:11463770-Risk Factors,
pubmed-meshheading:11463770-Telencephalon
|
pubmed:year |
2001
|
pubmed:articleTitle |
Angiotensinogen polymorphism M235T, carotid atherosclerosis, and small-vessel disease-related cerebral abnormalities.
|
pubmed:affiliation |
Department of Neurology, MRI Center, Karl-Franzens University, Graz, Austria. reinhold.schmidt@kfunigraz.ac.at
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|